Redmile Group, LLC Dynavax Technologies Corp Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.25 - $10.99 $6.4 Million - $9.7 Million	-882,814 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.57 - $11.18 $1.53 Million - $3.73 Million	-334,030 Reduced 27.45%	882,814 $8.68 Million
Q4 2020 Feb 16, 2021	SELL	$3.73 - $5.6 $4.97 Million - $7.46 Million	-1,331,776 Reduced 52.25%	1,216,844 $5.42 Million
Q3 2020 Nov 16, 2020	SELL	$4.32 - $11.7 $10.9 Million - $29.4 Million	-2,513,480 Reduced 49.65%	2,548,620 $11 Million
Q2 2020 Aug 14, 2020	BUY	$2.94 - $9.1 $14.9 Million - $46.1 Million	5,062,100 New	5,062,100 $44.9 Million

273

129M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.